According to the website of the National Medical Products Administration, recently, the Administration approved the listing of Zhuohe Pharmaceutical Group Co., Ltd.'s Class 1.1 innovative traditional Chinese medicine medicine Jiuwei cough relief oral liquid. The drug underwent a randomized, double-blind, placebo, and positive drug parallel controlled multicenter clinical trial. The clinical trial research results showed that the main therapeutic indicators, including cough disappearance rate and cough disappearance time, were better in the experimental group than in the placebo group and non inferior to the positive drug group. This medicine promotes lung function and relieves cough, and is used for cough with wind heat syndrome in traditional Chinese medicine differentiation of acute tracheobronchitis. The launch of this drug provides another treatment option for cough patients with acute tracheobronchitis. (Lai Xin She)